Ipilimumab blocks the effect of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), thereby enhancing the signaling between antigen-presenting cells and activated T-cells via the CD28 receptor on T-cells.
More to come later on your other questions.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.